Treace Medical Concepts, Inc. (TMCI)

NMS – Real Time Price. Currency in USD

2.29

+0.35 (18.30%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

213M

209M

187M

142M

Cost of goods sold

-43M

-41M

-35M

-28M

Gross Profit

170M

168M

152M

114M

Operating expenses (excl. COGS)

-224M

-203M

-149M

Operating Income

-54M

-56M

-51M

-35M

Non-operating income, total

-5M

-55K

-8M

Pretax income

-59M

-56M

-50M

-43M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-59M

-56M

-50M

-43M

Treace Medical Concepts, Inc. (TMCI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Treace Medical Concepts, Inc. (TMCI)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Treace Medical Concepts, Inc. (TMCI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Treace Medical Concepts, Inc. (TMCI)

Income Statement (Annual)

Income Statement (Annual)